Rana Atique Anwer, Sajid Ghafor, Huma Ahmad. (2022). Neoadjuvant Docetaxel Plus Carboplatin Versus Epirubicin Plus Cyclophosphamide Followed by Docetaxel in Triple-Negative, Early-Stage Breast Cancer. Pakistan Journal of Medical & Health Sciences, 16(08), 356. https://doi.org/10.53350/pjmhs22168356